Missouri Trust & Investment Co Sells 200 Shares of SPDR S&P Biotech ETF (NYSEARCA:XBI)

Missouri Trust & Investment Co cut its position in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 12.3% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 1,425 shares of the exchange traded fund’s stock after selling 200 shares during the quarter. Missouri Trust & Investment Co’s holdings in SPDR S&P Biotech ETF were worth $128,000 as of its most recent SEC filing.

A number of other institutional investors have also added to or reduced their stakes in the company. Howard Capital Management Group LLC grew its position in shares of SPDR S&P Biotech ETF by 2.4% in the 4th quarter. Howard Capital Management Group LLC now owns 254,166 shares of the exchange traded fund’s stock valued at $22,890,000 after acquiring an additional 6,052 shares during the period. Atomi Financial Group Inc. grew its holdings in SPDR S&P Biotech ETF by 224.2% during the fourth quarter. Atomi Financial Group Inc. now owns 7,248 shares of the exchange traded fund’s stock worth $653,000 after purchasing an additional 5,012 shares during the period. Gilman Hill Asset Management LLC acquired a new position in SPDR S&P Biotech ETF during the fourth quarter worth approximately $203,000. Mission Hills Financial Advisory LLC raised its stake in SPDR S&P Biotech ETF by 14.3% in the fourth quarter. Mission Hills Financial Advisory LLC now owns 36,111 shares of the exchange traded fund’s stock valued at $3,252,000 after buying an additional 4,531 shares during the period. Finally, Herbst Group LLC lifted its position in shares of SPDR S&P Biotech ETF by 19.9% in the fourth quarter. Herbst Group LLC now owns 4,830 shares of the exchange traded fund’s stock valued at $435,000 after buying an additional 800 shares during the last quarter.

SPDR S&P Biotech ETF Trading Up 2.9 %

XBI stock opened at $90.51 on Wednesday. SPDR S&P Biotech ETF has a 1-year low of $81.14 and a 1-year high of $105.47. The business’s 50 day simple moving average is $93.58 and its 200 day simple moving average is $96.95. The firm has a market capitalization of $6.90 billion, a PE ratio of 11.47 and a beta of 1.11.

About SPDR S&P Biotech ETF

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.